MORE►
oncology
[Image: Black_Kira/istockphoto]
Lantern Pharma Preps 2026 Trial for Rare Pediatric Brain Cancer After FDA Guidance
by Quincy Preston | Oct 14, 2025
The North Texas biotech, which uses AI to accelerate cancer drug development, received FDA feedback to advance a new clinical study targeting a rare childhood brain tumor.
by Lance Murray |
Jul 15, 2025
Argon—a provider of medical device solutions for Interventional radiology, vascular surgery, interventional cardiology, and oncology procedures—said its new Distribution & Education Center in Derby, England, will serve as a a hub for more than 80 countries across Europe, Africa, the Middle East, and the Asia-Pacific region.
MORE►
by Lance Murray |
Jun 16, 2025
The protein—implicated in blood cancers like leukemia, lymphoma, and multiple myeloma—was decoded in near-atomic detail by UT Southwestern researchers, including Nobel Prize winner Bruce Beutler. In lab models, turning off midnolin wiped out up to 92% of cancer cells—with minimal impact on healthy ones, according to UT Southwestern.
MORE►
Jason Hammonds, COO of oncology and specialty for McKesson (left) and Marcus Neubauer, MD, chief medical officer for The US Oncology Network [Photos: LinkedIn]
McKesson Launches Initiative to Advance Precision Medicine in Community Oncology
by Lance Murray | Apr 22, 2025
Precision Care Companion (PCC) is a consortium of industry experts, led by McKesson, designed to help healthcare practices improve patient care.
MORE►
by Lance Murray |
Aug 26, 2024
Florida-based Core Ventures was established by the Florida Cancer Specialists & Research Institute, a physician-owned community oncology practice. With the multi-billion-dollar acquisition, CORE Ventures will join McKesson's US Oncology Network to advance "affordable cancer care and better patient outcomes."
MORE►
by Lance Murray |
Jun 1, 2023
Expanding a collaboration they announced in January, the two companies aim to drive "the future of cancer care" with the new platform, enabling novel insights for precision medicine, therapeutic development, and clinical trials management for academic and biopharma researchers.
MORE►
by Lance Murray |
Mar 7, 2023
NanOlogy said the new patent covers a method of treating cancer by intratumoral administration of large surface area microparticle taxanes in combination with systemic administration of immune checkpoint inhibitors. “The goal is to identify which combinations can increase the immune response, thereby increasing the overall solid tumor response to treatment," said NanOlogy Chief Medical Officer Gere DiZerega.
MORE►
Video still from Lupagen's website. [Image: Lupagen}
Dallas’ Lupagen Aims To Change the Way Cancer, Other Disorders Are Treated
by Kevin Cummings | Jun 2, 2022
Instead of shipping a patient's blood to a lab for customized cell therapy, Lupagen does the procedure "in vivo," using a dialysis-like treatment at the patient's bedside. Now it's collaborating with Umoja Biopharma to use its drug-delivery tech to place targeted immunotherapies in patients.
“We're able to deliver different types of gene therapies in a closed system," Lupagen's CEO says, calling the tech a "bridge to the future."
“We're able to deliver different types of gene therapies in a closed system," Lupagen's CEO says, calling the tech a "bridge to the future."
MORE►
by Alex Edwards |
Dec 9, 2020
Ontada builds on McKesson's long history in community oncology. The new business will combine McKesson's real-world data and research capabilities, technology, and ties to the national community oncology network to transform cancer care.
MORE►
by Alex Edwards |
Nov 18, 2020
Lantern Pharma amassed 1 billion data points on its proprietary artificial intelligence platform, which it believes is the most of any company in biotech. Now, the company is able to reduce cost, time, and risk to establish a more sustainable route in oncology drug development.
MORE►
by Payton Potter |
May 2, 2019
Using a patient's molecular makeup, Caris and Pharmatech aim to find the perfect clinical trial for each cancer patient—and enroll them in as little as 10 days.
MORE►
Researcher’s Book Offers New Hope in Cancer Research
by Patrick Kobler | Feb 9, 2016
We connected with Dr. Theodora Ross, author of A Cancer in the Family, on why she came to DFW, UT Southwestern’s work in cancer genetics, and for her thoughts on how we can battle cancer more effectively.
MORE►
![Erica Kosemund, Chief Brand Officer, Choctaw Nation of Oklahoma; Gillian Breidenbach, Chief Partnership Officer, North Texas FWC Organizing Committee; Chief Gary Batton, Chief of Choctaw Nation of Oklahoma; Monica Paul, Executive Director of Dallas Sports Commission and President of North Texas FWC Organizing Committee; John Hobbs, Senior Executive Officer of Communications, Choctaw Nation of Oklahoma; and Heidi Grant, Senior Executive Officer of Commerce Administration, Choctaw Nation of Oklahoma, celebrate Choctaw Casinos & Resorts becoming an Official Dallas World Cup 2026 Host City Supporter. [Photo: North Texas FWC Organizing Committee/Choctaw Casinos & Resorts]](https://s24806.pcdn.co/wp-content/uploads/2025/12/FIFA-Choctaw-dec-2025.jpg)
